Achieve Life Sciences (ACHV) Announces Patent Granted in U.S. for Novel Analogs of Cytisinicline for Use in CNS and Addiction Indications

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Achieve Life Sciences (ACHV) Announces Patent Granted in U.S. for Novel Analogs of Cytisinicline for Use in CNS and Addiction Indications

Achieve Life Sciences (ACHV) Prices 476.19K Share Common Offering at $10.50/Sh

August 4, 2020 9:02 AM EDT

Achieve Life Sciences, Inc. (NASDAQ: ACHV) today announced the pricing of an underwritten public offering of 476,187 shares of its common stock at a price to the public of $10.50 per share. In addition, Achieve is offering to certain investors whose purchase of common stock would result in the investor, together with its... More

Achieve Life Sciences (ACHV) Announces Proposed Common Share Offering

August 3, 2020 4:01 PM EDT

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced a proposed underwritten public offering in which it intends to offer and sell shares of its... More